Covid, “immunocompromised fourth dose flop”: Gimbe report

The fourth dose of the anti-Covid vaccine does not take off indeed it is “a flop”. In a month and a half “only 70,598 fourth doses administered to the immunocompromised with a national coverage of 8.9%”. This was revealed by the monitoring of the Gimbe Foundation in the week of 6-12 April. “After a month and a half from the green light for the most fragile patients – underlines the president of the Gimbe Foundation Nino Cartabellotta – the small coverage and the relevant regional differences document a real flop, fueled by a sense of mistrust for a further recall”. “This is why the administration of a further reminder to the recently enlarged audience of over 80s, guests of RSAs and people in the 60-79 age group with concomitant pathologies cannot be entrusted exclusively to voluntary membership, but requires active calling strategies, in fact never implemented in a systematic way “, concludes the president Cartabellotta.